DermTech, Inc. Profile Avatar - Palmy Investing

DermTech, Inc.

DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive genomics tests to diagnosis skin cancer, inflammatory diseases, and aging-related conditions in the United States. It offers DermTech Melanoma Test (DMT), a gene expr…

Medical - Diagnostics & Research
US, La Jolla [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
Worldwide · Competitors Table
Worldwide · Subsidiaries Table
Subsidiary Private? Country City
- - - -
End of DMTK's Analysis
CIK: 1651944 CUSIP: 24984K105 ISIN: US24984K1051 LEI: - UEI: -
Secondary Listings
DMTK has no secondary listings inside our databases.